Minimally invasive technology would allow for percutaneous placement of a paddle electrode Renowned pain specialist Dr. Sean Li to present on this innovative tool for lower back pain EDEN PRAIRIE, ...

Nevro announced today that it received FDA approval for an AI-powered, personalized pain management platform for spinal cord ...

personalized pain management platform powering the HFX iQ spinal cord stimulation (SCS) system. Building on a foundation of ...

Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical ...

The neurosurgeons at Austin Brain and Spine collectively have over 100 years of medical experience. Dr. Alexa Bodman joined Studio 512 to discuss what the doctors treat, and specifically how they ...

Nevro earned FDA approval and began a limited market release of its HFX iQ spinal cord stimulator with HFX AdaptivAI, the company said Sept. 24.

Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical regions of the central nervous system, such as the pons, thalamus, and spinal ...

Los Angeles County Department of Public Health announced that two human cases of Baylisascaris procyonis – a parasite that ...

Steve Waddell, the founder, president and CEO of Nasoni, recently landed a $2.58 million federal grant to integrate advanced ...

A Santa Rosa resident was handed down a sentence of 39 years to life in prison for a 2022 shooting that turned a man into a ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...

Announced in 2022, project is listed as being a high priority, but Veterans Administration has yet to make specific budget ...